 |
|
|
|
Ambler class |
Protein name |
PDB code |
Resolution (Å) |
Release date |
UniProt code |
PubMed ID |
DOI |
PDB |
Mutations |
Ligands |
Space group |
Unit cell parameters |
Z value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ▲ ▼ | ▲ ▼ | ▲ ▼ | ▲ ▼ | ▲ ▼ | ▲ ▼ | ||||||||
| D | OXA-58 | 4OH0 | 1.30 | 2014-02-26 | Q2TR58 | 24468777 | 10.1128/AAC.01983-13 | pdb | CL KCX | P 21 21 21 | 37.121 65.408 93.758 ♦ 90.00 90.00 90.00 | 4 | |
| D | OXA-58 | 4Y0O | 2.37 | 2016-01-13 | Q2TR58 | 26459904 | 10.1128/AAC.01393-15 | pdb | KCX | P 21 21 21 | 37.074 67.038 93.515 ♦ 90.00 90.00 90.00 | 4 | |
| D | OXA-58 | 4Y0T | 2.30 | 2016-01-13 | Q2TR58 | 26459904 | 10.1128/AAC.01393-15 | pdb | KCX | P 1 21 1 | 37.017 65.095 191.964 ♦ 90.00 91.28 90.00 | 8 | |
| D | OXA-58 | 4Y0U | 2.60 | 2016-01-13 | Q2TR58 | 26459904 | 10.1128/AAC.01393-15 | pdb | *ALP KCX | P 1 21 1 | 36.943 65.659 191.594 ♦ 90.00 91.70 90.00 | 8 | |
| D | OXA-58 | 4Z9Q | 2.23 | 2016-04-13 | B2I3T3 | pdb | KCX | P 1 21 1 | 37.360 39.790 72.090 ♦ 90.00 91.20 90.00 | 2 | |||
| D | OXA-58 | 5BOH | 1.80 | 2015-12-30 | Q2TR58 | 26701320 | 10.1371/JOURNAL.PONE.0145869 | pdb | KCX SO4 | H 3 | 75.290 75.290 120.682 ♦ 90.00 90.00 120.00 | 9 | |
| D | OXA-58 | 7VVI | 1.40 | 2022-11-23 | Q2TR58 | pdb | *MER KCX SO4 | H 3 | 75.380 75.380 119.531 ♦ 90.00 90.00 120.00 | 9 | |||
| D | OXA-58 | 7VX3 | 1.80 | 2022-11-23 | Q2TR58 | pdb | *MER DWZ KCX SO4 | H 3 | 75.290 75.290 119.470 ♦ 90.00 90.00 120.00 | 9 | |||
| D | OXA-58 | 7VX6 | 1.70 | 2022-11-23 | Q2TR58 | pdb | *MER DWZ KCX SO4 | H 3 | 75.240 75.240 119.600 ♦ 90.00 90.00 120.00 | 9 |
Statistics (number of structures): Overall (1663); class A (626); subclass B1 (403); subclass B2 (16); subclass B3 (104); class C (246); class D (268).
Last updated: January 08, 2024.
If you use BLDB please cite: Naas, T.; Oueslati, S.; Bonnin, R. A.; Dabos, M. L.; Zavala, A.; Dortet, L.; Retailleau, P.; Iorga, B. I., Beta-Lactamase DataBase (BLDB) – Structure and Function. J. Enzyme Inhib. Med. Chem. 2017, 32, 917-919.
The development of the BLDB database is funded in part by the JPIAMR transnational project DesInMBL, the Région Ile-de-France (DIM Malinf) and the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT).
Contact: contact@bldb.eu